Benitec Biopharma, Inc. (BNTC)
8.98
-0.60
(-6.26%)
USD |
NASDAQ |
Oct 02, 16:00
8.95
-0.03
(-0.33%)
After-Hours: 20:00
Benitec Biopharma Shareholders Equity (Quarterly) : 177.01M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 177.01M |
| March 31, 2026 | 183.33M |
| December 31, 2025 | 187.36M |
| September 30, 2025 | 93.60M |
| June 30, 2025 | 97.30M |
| March 31, 2025 | 97.57M |
| December 31, 2024 | 75.94M |
| September 30, 2024 | 64.18M |
| June 30, 2024 | 47.25M |
| March 31, 2024 | 11.50M |
| December 31, 2023 | 15.47M |
| September 30, 2023 | 22.31M |
| June 30, 2023 | 0.202M |
| March 31, 2023 | 4.713M |
| December 31, 2022 | 8.994M |
| September 30, 2022 | 14.61M |
| June 30, 2022 | 2.882M |
| March 31, 2022 | 7.52M |
| December 31, 2021 | 10.84M |
| September 30, 2021 | 15.48M |
| June 30, 2021 | 20.01M |
| Date | Value |
|---|---|
| March 31, 2021 | 10.93M |
| December 31, 2020 | 14.62M |
| September 30, 2020 | 7.736M |
| June 30, 2020 | |
| March 31, 2020 | 12.34M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | 16.59M |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | 15.10M |
| June 30, 2016 | |
| March 31, 2016 | 19.11M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
| Biogen, Inc. | 18.85B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 182.62M |
| Total Liabilities (Quarterly) | 5.61M |
| Debt to Equity Ratio | 0.0043 |
| Current Ratio | 34.00 |
| Net Debt Paydown Yield | 0.01% |